A Michigan Medicine team looks into the prevalence of NAFLD in patients with heart failure with preserved ejection fraction.
Liver Conditions & Procedures
A team of experts compared rates of cirrhosis, cardiovascular disease and metabolic abnormalities between patients with fatty liver disease who were of normal weight and overweight or obese.
An international team of researchers conducts a study that defines a simple, low-cost blood test that yields high-performing results in the elimination of hepatitis C.
A collaborative U-M team shows that liver injury is less likely to originate from popular cancer immunotherapy drug, pembrolizumab, than tumor progression.
U-M researchers identify a potential treatment for non-alcoholic fatty liver disease.
An enzyme’s newly discovered ability to spur the body to prevent or repair acute liver injury in mice could be harnessed as a therapy or used as a biomarker.<